May 7, 2020 / 1:41 PM / a month ago

BRIEF-Livzon Pharmaceutical Group Gets Receipt Of Notice Of Approval For Clinical Trial On A Drug​

May 7 (Reuters) - Livzon Pharmaceutical Group Inc :

* GETS APPROVAL FOR CLINICAL TRIAL BY NMPA ON RECOMBINANT TUMOR ENZYME SPECIFIC INTERFERON -2B FC FUSION FOR INJECTION Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below